(Bloomberg) -- Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move surgeons warned would set back the available treatment options ...
One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...
A UK-wide research team, led by the University of Oxford's Nuffield Department of Surgical Sciences, has launched a major international study to improve surgical treatment for people suffering from ...
Johnson & Johnson (NYSE:JNJ) is reportedly halting international sales of its Linx Reflux Management System, a device used to treat chronic acid reflux. In a letter to doctors dated September 17, the ...
March 17--At the Cuyuna Regional Medical Center in Crosby, a 145-bed hospital on the Iron Range, Dr. Paul Severson and Dr. Howard McCollister are two of only four surgeons in Minnesota implanting Linx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results